SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-103705
Filing Date
2016-03-09
Accepted
2016-03-09 07:45:46
Documents
15
Period of Report
2016-03-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-6019_18k.htm 8-K 21495
2 EX-99.1 a16-6019_1ex99d1.htm EX-99.1 19038
3 GRAPHIC g60191mmi001.gif GRAPHIC 32356
4 GRAPHIC g60191mmi002.gif GRAPHIC 147306
5 GRAPHIC g60191mmi003.gif GRAPHIC 46477
6 GRAPHIC g60191mmi004.gif GRAPHIC 59046
7 GRAPHIC g60191mmi005.gif GRAPHIC 30931
8 GRAPHIC g60191mmi006.gif GRAPHIC 123464
9 GRAPHIC g60191mmi007.gif GRAPHIC 95520
10 GRAPHIC g60191mmi008.gif GRAPHIC 29602
11 GRAPHIC g60191mmi009.gif GRAPHIC 118604
12 GRAPHIC g60191mmi010.gif GRAPHIC 60477
13 GRAPHIC g60191mmi011.gif GRAPHIC 25210
14 GRAPHIC g60191mmi012.gif GRAPHIC 94434
15 GRAPHIC g60191mmi013.gif GRAPHIC 17954
  Complete submission text file 0001104659-16-103705.txt   1256501
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 161493381
SIC: 2834 Pharmaceutical Preparations